FORMULATION AND EVALUATION OF SIMVASTATIN LOADED MICROEMULSION BASED GEL: IN VITRO CHARACTERIZATION

The Simvastatin loaded microemulsion based gel was formulated and in-vitro evaluation was done for the treatment of diabetic wound healing. Simvastatin is BCS class II drug which promotes wound healing by increasing the production of vascular endothelial growth factor (VEGF). Microemulsions (MEs) are oil and water colloidal system stabilized by the mixture of surfactant and co-surfactant offering enhance skin permeability for both hydrophobic and hydrophilic drugs. At first, microemulsion (ME) was prepared by water titration method and the existence of ME region was determined using pseudo-ternary phase diagram. Formulations were prepared using oil (oleic acid), Tween 80 and PEG 400 as surfactant and co-surfactant. Optimization of formulation was done using 32 factorial designs. Carbopol 940 was used as gelling agent for preparing microemulsion gel. The formulations were evaluated for physical appearance globule size, polydispersity index, zeta potential, percent transmittance, thermodynamic stability, dilution test, drug content, and in vitro drug release. The optimized formulation of ME showed average globule size of 151 nm and the optimized ME gel had a homogeneous texture, showed good spreadability and in vitro drug release. The present study indicates the simvastatin loaded microemulsion gel could act as promising vehicle for topical drug delivery of drug for diabetic wound healing.

Improved in vitro Release and ex vivo Permeation of Zotepine as Microemulsion Gel Formulation through Transdermal Application

Zotepine is atypical antipsychotic drug with poor oral bioavailability due to first-pass metabolism and poor aqueous solubility. The objective of the current investigation was preparation and ex vivo characterization of Zotepine (ZT) loaded microemulsion (ZT-ME) and microemulsion gel (ZT-MEG) for enhanced transdermal delivery. ZT-ME formulation was prepared with 7.5% oleic acid, 30% w/v of Tween80 and 30%w/v of absolute ethanol as oil, surfactant and cosurfactant, respectively. Optimized ZT-ME formulation was selected and converted to ZT-MEG using carbopol as gelling agent. ZT-ME and ZT-MEG subjected to in vitro release and ex vivo permeation studies through rat skin, comparison with ZT coarse suspension (ZT-CS). ZT-ME formulation showed desirable physicochemical properties and stable with dilution stress. Prepared ZT-MEG formulation has showed better rheological behaviour and good spreadability. ZT-ME and ZT-MEG showed prolonged release compared with ZT-CS formulation over 24 h. ZT-ME and ZT-MEG exhibited 5-folds and 3.5-folds in permeation through rat skin compared with ZT-CS formulation. Overall, ZT-MEG formulation could be considered as an alternative delivery approach for enhanced skin delivery.

FORMULATION OF MICROEMULSION BASED GEL OF SALBUTAMOL SULPHATE AND IT’S IN VITRO STUDIES

Objective: The aim of this study was to develop a microemulsion based gel system considering transdermal delivery of Salbutamol with a purpose to increase the solubility and membrane drug deliverance. Methods: Oleic acid was favored for oil phase owing to the proficiency of solubility in this study. Despite surfactant and co-surfactant was determined by virtue of their solubilizing strength wherewith they developed MEs. Accomplishing Franz diffusion cells equipped with cellulose membrane for in vitro study. The Polymer carbopol 934 were used for based gel preparation to enhance the viscosity of microemulsion for transdermal utilization. The advanced micro emulsion-based gel, which was assessed for pH, centrifugation, spreadability conductivity, drug content, viscosity, SEM, XRD and stability studies. Results: The process of drug escape from microemulsion gel-based was noticed to pursue Korsmeyer-peppas model kinetics. The designed, microemulsion gel-based displayed acceptable stability layer than 3 mo. Drug release microemulsion within 24 h was observed 74%. Conclusion: The results illustrate that deliberated effort to establish microemulsion based gel (F3) was likely to produce sustained action of drug release (78.3%) and be permitted auspicious vehicle for transdermal distribution of Salbutamol.